Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Klein

Showing results (561-570 of 1,611) with videos related to

Pageof 162
Sort By:
European Cytokine Network|April 22, 1999
Interleukin-6 receptor signaling. I. gp80 and gp130 receptor interaction in the absence of interleukin-6J P Gaillard, J C Mani, J Liautard, et al.
European Cytokine Network|September 8, 1999
Interleukin-6 receptor signaling. II. Bio-availability of interleukin-6 in serumJ Gaillard, M Pugnière, J Tresca, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|August 10, 2000
[Lethal osteochondrodysplasias: prenatal and postnatal differential diagnosis]I Sauer, B Klein, B Leeners, et al.
Cancer|March 1, 1989
Spontaneous secretion of tumor necrosis factor-beta by human myeloma cell linesR Bataille, B Klein, M Jourdan, et al.
Journal of Interferon Research|October 1, 1994
Pharmacokinetics of interleukin-6 during therapy with anti-interleukin-6 monoclonal antibodies: enhanced clearance of interleukin-6 by a combination of three anti-interleukin-6 antibodiesF A Montero-Julian, E Gautherot, J Wijdenes, et al.
Bulletin De La Societe De Pathologie Exotique Et De Ses Filiales|January 1, 1987
[Epidemiology of Pseudomonas aeruginosa in Mauritania: study of 239 strains of various origins]J F Vieu, J P Lepers, G Chamoiseau, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|December 21, 2004
[Transparency in patient care -- survey of bedsores on communal level to promote quality assurance]S Steingass, B Klein, K Pavel, et al.
Neuroscience Letters|April 11, 2013
Increased serum brain-derived neurotrophic factor (BDNF) levels in patients with narcolepsyAnders B Klein, Poul Jennum, Stine Knudsen, et al.
Blood|December 1, 1993
Plasma cell labeling index, beta 2-microglobulin, and C-reactive protein: what is the best combination for myeloma prognosis?M Boccadoro, G Gallone, R Frieri, et al.
Journal of Medical Economics|October 6, 2018
The economic burden of uncontrolled gout: how controlling gout reduces costNatalia M Flores, Javier Nuevo, Alyssa B Klein, et al.
Pageof 162

Showing results (561-570 of 1,611) with videos related to

Sort By:
Pageof 162
European Cytokine Network|April 22, 1999
Interleukin-6 receptor signaling. I. gp80 and gp130 receptor interaction in the absence of interleukin-6J P Gaillard, J C Mani, J Liautard, et al.
European Cytokine Network|September 8, 1999
Interleukin-6 receptor signaling. II. Bio-availability of interleukin-6 in serumJ Gaillard, M Pugnière, J Tresca, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|August 10, 2000
[Lethal osteochondrodysplasias: prenatal and postnatal differential diagnosis]I Sauer, B Klein, B Leeners, et al.
Cancer|March 1, 1989
Spontaneous secretion of tumor necrosis factor-beta by human myeloma cell linesR Bataille, B Klein, M Jourdan, et al.
Journal of Interferon Research|October 1, 1994
Pharmacokinetics of interleukin-6 during therapy with anti-interleukin-6 monoclonal antibodies: enhanced clearance of interleukin-6 by a combination of three anti-interleukin-6 antibodiesF A Montero-Julian, E Gautherot, J Wijdenes, et al.
Bulletin De La Societe De Pathologie Exotique Et De Ses Filiales|January 1, 1987
[Epidemiology of Pseudomonas aeruginosa in Mauritania: study of 239 strains of various origins]J F Vieu, J P Lepers, G Chamoiseau, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|December 21, 2004
[Transparency in patient care -- survey of bedsores on communal level to promote quality assurance]S Steingass, B Klein, K Pavel, et al.
Neuroscience Letters|April 11, 2013
Increased serum brain-derived neurotrophic factor (BDNF) levels in patients with narcolepsyAnders B Klein, Poul Jennum, Stine Knudsen, et al.
Blood|December 1, 1993
Plasma cell labeling index, beta 2-microglobulin, and C-reactive protein: what is the best combination for myeloma prognosis?M Boccadoro, G Gallone, R Frieri, et al.
Journal of Medical Economics|October 6, 2018
The economic burden of uncontrolled gout: how controlling gout reduces costNatalia M Flores, Javier Nuevo, Alyssa B Klein, et al.
Pageof 162